Interleukin 18 as a new inflammatory mediator in left ventricular hypertrophy in children with end-stage renal disease

Interleukin 18 as a new inflammatory mediator in left ventricular hypertrophy in children with end-stage renal disease

Left ventricular hypertrophy (LVH) represents an important determinant of increased cardiovascular morbidity and mortality (CV) in end-stage renal disease (ESRD) patients. The role of inflammatory markers in pathogenesis of LVH in children with ESRD is not fully described. The aim of this study is t...

Full description

Bibliographic Details
Main Authors: Ahlam Badawy, Dalia A Nigm, Ghada M Ezzat, Yasser Gamal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2020;volume=31;issue=6;spage=1206;epage=1216;aulast=Badawy

Internet

http://www.sjkdt.org/article.asp?issn=1319-2442;year=2020;volume=31;issue=6;spage=1206;epage=1216;aulast=Badawy

Similar Items